近期感染与未感染SARS-CoV-2的2,777,768名退伍军人中糖尿病的发病率
本研究利用退伍军人健康管理局数据开展回顾性队列研究,纳入无既往糖尿病的SARS-CoV-2拭子阳性者126,710例和拭子阴性且有一次以上实验室检查者2,651,058例。男性中SARS-CoV-2感染与更高的新发糖尿病风险相关(120天OR 2.56,95%CI 2.32-2.83;全程OR 1.95,95%CI 1.80-2.12),女性中无显著关联。住院亚组分析结果与主分析一致。
要点
- 男性中SARS-CoV-2感染与更高的新发糖尿病风险相关,120天OR 2.56(95%CI 2.32-2.83)。
- 女性中SARS-CoV-2感染与新发糖尿病风险无显著关联(120天OR 1.21,95%CI 0.88-1.68)。
- 住院亚组中男性SARS-CoV-2感染仍与更高糖尿病风险相关(120天OR 1.42,95%CI 1.22-1.65)。
核心结论
- SARS-CoV-2感染与男性更高的新发糖尿病风险相关,女性中未观察到该关联,即使在校正住院相关监测后仍如此。
研究设计与样本
- 回顾性队列研究,使用退伍军人健康管理局数据。
- 暴露组为2020年3月1日至2021年3月10日期间一次以上鼻拭子SARS-CoV-2阳性且无既往糖尿病的患者,n=126,710。
- 非暴露组为2020年3月1日至2021年3月31日期间无阳性拭子且一次以上实验室检查的患者,n=2,651,058。
- 暴露组索引日期为首次阳性拭子日期,非暴露组为合格实验室检查当月随机日期。
- 拟合性别分层logistic回归模型,分析SARS-CoV-2与120天内及截至2021年6月1日全程随访中新发糖尿病的关联。
主要发现
- 男性中SARS-CoV-2与更高的新发糖尿病风险相关:120天OR 2.56(95%CI 2.32-2.83),全程OR 1.95(95%CI 1.80-2.12)。
- 女性中SARS-CoV-2与新发糖尿病风险无显著关联:120天OR 1.21(95%CI 0.88-1.68),全程OR 1.04(95%CI 0.82-1.31)。
- 住院男性中SARS-CoV-2与更高糖尿病风险相关:120天OR 1.42(95%CI 1.22-1.65),随访结束时OR 1.32(95%CI 1.16-1.50)。
- 住院女性中SARS-CoV-2与糖尿病风险无显著关联:120天OR 0.72(95%CI 0.34-1.52),随访结束时OR 0.80(95%CI 0.44-1.45)。
- 性别与SARS-CoV-2交互作用P值均<0.1。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine associations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection/coronavirus disease 2019 with incident diabetes. RESEARCH DESIGN AND METHODS: We conducted a retrospective cohort study using Veterans Health Administration data. We defined all patients without preexisting diabetes with one or more nasal swabs positive for SARS-CoV-2 (1 March 2020-10 March 2021; n = 126,710) as exposed and those with no positive swab and one or more laboratory tests (1 March 2020-31 March 2021; n = 2,651,058) as unexposed. The index date for patients exposed was the date of first positive swab and for patients unexposed a random date during the month of the qualifying laboratory test. We fit sex-stratified logistic regression models examining associations of SARS-CoV-2 with incident diabetes within 120 days and all follow-up time through 1 June 2021. A subgroup analysis was performed among hospitalized subjects only to help equalize laboratory surveillance. RESULTS: SARS-CoV-2 was associated with higher risk of incident diabetes, compared with no positive tests, among men (120 days, odds ratio [OR] 2.56 [95% CI 2.32-2.83]; all time, 1.95 [1.80-2.12]) but not women (120 days, 1.21 [0.88-1.68]; all time, 1.04 [0.82-1.31]). Among hospitalized participants, SARS-CoV-2 was associated with higher risk of diabetes at 120 days and at the end of follow-up in men (OR 1.42 [95% CI 1.22-1.65] and 1.32 [1.16-1.50], respectively) but not women (0.72 [0.34-1.52] and 0.80 [0.44-1.45]). Sex ∗ SARS-CoV-2 interaction P values were all <0.1. CONCLUSIONS: SARS-CoV-2 is associated with higher risk of incident diabetes in men but not in women even after greater surveillance related to hospitalization is accounted for.
引用
- Wander PL, Lowy E, Beste LA, et al. The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection. Diabetes Care. 2022. PMID: 35085391. doi:10.2337/dc21-1686
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。